Research Insight

Study finds evidence of virus in human prostate cancer cells

US scientists have found evidence of a virus in malignant human prostate cancer cells, but more research is needed before we know it is a definite factor in cancer development. The virus, xenotropic murine leukaemia virus-related virus (XMRV), is...

UPCI researchers develop biomarker measurement that could lead to tailored cancer treatments

University of Pittsburgh Cancer Institute have developed an accurate method to measure a biomarker that could predict which cancer patients will respond to certain chemotherapies. The identification of molecular markers to guide treatment decisions for patients with advanced disease...

Autoimmune Response Can Induce Pancreatic Tumor Rejection

According to new scientific findings published in Cancer Research, a journal of the American Association for Cancer Research stating that, Immune responses are capable of killing tumors before they can be directed toward normal body tissue. Lead researcher...

Clinical Trial at CINJ examines shorter course of Radiation Treatment for Early-Stage Breast Cancer

Researchers at The Cancer Institute of New Jersey (CINJ) have launched a clinical trial that focuses on a shorter course of radiation treatment for those with early-stage breast cancer. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson...

Technology Can Reverse The Effects of Some Strokes

According to the National Stroke Association, Stroke is the third leading cause of death in America and the number one cause of adult disability. According to Michael J. Alexander, M.D., director of the Neurovascular Center and director of endovascular...

Calypso Medical Study shows potential for improving radiotherapy treatment accuracy of deadly pancre

Calypso Medical Technologies, Inc.,  announced the publication of data from a clinician sponsored investigational study conducted at the University of Pennsylvania, demonstrating the utility of the Calypso® System in tracking tumor movement in the pancreas. The data will be...

Botox-maker Allergan Inc.announced the second-quarter profit early Friday

Botox-maker Allergan Inc. announced the second-quarter profit early Friday, the figures were substantially higher, attributable in part to the company's cost-cutting measures. Botox-maker Allergan Inc. announced the second-quarter profit early Friday, the figures were substantially higher, attributable in part to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read